NCT05901935 2023-06-13DP303c in Patients With HER2-positive Advanced Breast CancerCSPC ZhongQi Pharmaceutical Technology Co., Ltd.Phase 3 Not yet recruiting420 enrolled
NCT04185649 2019-12-04The Efficacy and Safety of BAT8001 Injection for the Treatment of HER2-positive Advanced Breast CancerBio-Thera SolutionsPhase 3 Unknown410 enrolled